NCT02173223View on ClinicalTrials.gov

A Study to Assess the Effect of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Uncontrolled Advanced Glaucoma With Prior Failed Trabeculectomy or Tube Shunt

PHASE2UnknownINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

June 30, 2014

Primary Completion Date

February 28, 2015

Conditions
Advanced Glaucoma
Interventions
DRUG

Rho-Kinase Inhibitor

Trial Locations (1)

10003

Glaucoma Associates of New York, New York

Sponsors
All Listed Sponsors
lead

New York Glaucoma Research Institute

OTHER